Navigation Links
Neurocrine Biosciences Reports Third Quarter 2008 Results
Date:10/28/2008

ces with respect to the Company's clinical programs include, but are not limited to, risk that the Company's elagolix Phase II clinical trials will fail to demonstrate that elagolix is safe and effective; risk that preclinical data will indicate that urocortin 2 is not suitable for further clinical studies; risk that the CRF1 receptor antagonist candidate's Phase II proof of concept clinical studies will not support further clinical studies; and overall risk that the Company's clinical candidates will not proceed to later stage clinical trials. Risks associated with the Company's indiplon program include, but are not limited to, risk that indiplon approval and subsequent commercialization may be indefinitely delayed or never accomplished. With respect to its pipeline overall, the Company faces risk that it will be unable to raise additional funding required to complete development of all of its product candidates; risk relating to the Company's dependence on contract manufacturers for clinical drug supply; risks associated with the Company's dependence on corporate collaborators for commercial manufacturing and marketing and sales activities; uncertainties relating to patent protection and intellectual property rights of third parties; risks and uncertainties relating to competitive products and technological changes that may limit demand for the Company's products; and the other risks described in the Company's report on Form 10-K for the year ended December 31, 2007 and report on Form 10Q for the quarter ended June 30, 2008. Neurocrine undertakes no obligation to update the statements contained in this press release after the date hereof.

NEUROCRINE BIOSCIENCES, INC.

Condensed Consolidated Statements of Operations

(in thousands, except for per share data)

Three Months Ended Nine Months Ended

September 30,
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Webcast Alert: Neurocrine Announces 3Q 08 Financial Results
2. Neurocrine Biosciences to Present at the Oppenheimer 19th Annual Healthcare Conference
3. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2008 Financial Results
4. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
5. Neurocrine Biosciences to Present at Thomas Weisel Healthcare Conference and the NewsMakers in the Biotech Industry Conference
6. Neurocrine Biosciences Reports Second Quarter 2008 Results
7. Neurocrine Biosciences Announces Conference Call and Webcast To Present Second Quarter 2008 Financial Results
8. Neurocrine Biosciences to Present at the 2008 Citi Investment Research Global Health Care Conference
9. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2008 Financial Results
10. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2007 Financial Results
11. Neurocrine Announces Appointment of Kevin Gorman, Ph.D., as President and Chief Executive Officer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , REYKJAVIK, Iceland, Novemb...nc. (Nasdaq: DCGN ) today announced the approval o...uptcy Court for the District of Delaware,(the "Ban...y petition for,relief under Chapter 11 of the Unit...t. , The orders issued by the Bankruptcy ...
(Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-Asia...Food & Drug Administration (SFDA) has approved...r its oral insulin project,(Nodlin), an innovative...pproval allows Biolaxy to initiate its first phase...er characteristic of high blood glucose and poor,m...
(Date:11/24/2009)... , , Primary efficacy endpoint has been me...t endometrial cancer, , QUEBEC CITY, Nov. 24 ...SDAQ: AEZS ; TSX: AEZ) (the "Company"), a global ...rapy and oncology, today announced positive effica...otoxic peptide conjugate, AEZS-108 (formerly AN-15...
(Date:11/24/2009)... , SAN DIEGO, Nov. 24, 2009 /PRNewswire-Fi...ARNA ) announced today that the company is sched...ealth Care Conference on December 1, 2009 at 11:30... New York Palace Hotel in New York City. Jack Lief...s scheduled to provide an overview of the company,...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3
...ion of,North America and its partner Helsinn Healt...ug Administration (FDA) has approved a new oral,fo... for the prevention of,chemotherapy-induced nausea...al administration is indicated for the prevention ... repeat courses of moderately emetogenic,chemother...
...-- WuXi PharmaTech (NYSE:,WX), a leading pharmaceu...nd development outsourcing company with operations...hat it has promoted Dr. Rujian Ma to Vice,Presiden...scom.com/cgi-bin/prnh/20040705/CNM002LOGO ), Dr.... Scientific,Officer of WuXi PharmaTech., "I am ve...
...e-FirstCall/ - OncoGenex,Pharmaceuticals (NASDAQ: ...s,custirsen sodium, received Fast Track designatio...n combination with docetaxel for progressive,metas...ting five Phase 2,clinical studies in prostate, lu...he production of a specific protein, clusterin, as...
Other Biology Technology:FDA Approves ALOXI(R) (Palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting 2FDA Approves ALOXI(R) (Palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting 3WuXi PharmaTech Promotes Dr. Rujian Ma to VP of Synthetic Chemistry 2FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals' Lead Product Candidate OGX-011 2FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals' Lead Product Candidate OGX-011 3FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals' Lead Product Candidate OGX-011 4
(Date:11/24/2009)...search on bacterial communities throughout six lar...poral patterns, suggesting that scientists could u...mate change in the polar regions. The study, publi... Academy of Sciences Early Edition, shows that ba...hronously over time, correlating with seasonal shi...
(Date:11/23/2009)...dence that the "synergistic" effect of early-life ... and indoor endotoxin causes more harm to developi..., Environmental health scientists at the Universi...wn that children exposed to both high levels of tr...g early life are six times more likely to experien...
(Date:11/23/2009)...pplied mathematicians dissected the morphology of ...ristic long leaf with a saddle-like arc midsection...imple cause of the lily,s fan-like shapeelastic re...l growthwas revealed by using an equally simple te... a postdoctoral student at Harvard,s School of Eng...
Breaking Biology News(10 mins):Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2The cause behind the characteristic shape of a long leaf revealed 2Obama Administration Advances Long Term Services and Supports in Health Care Reform 50938 1Obama Administration Advances Long Term Services and Supports in Health Care Reform 50938 2ICSI Plans Symposium on New Depression Treatment Program That Is Improving Patient Outcomes Five Fold Over Typical Primary Care 50936 1ICSI Plans Symposium on New Depression Treatment Program That Is Improving Patient Outcomes Five Fold Over Typical Primary Care 50936 2Genes Linked to Cholesterol in Cells Are Identified 50935 1Genes Linked to Cholesterol in Cells Are Identified 50935 2
...sh are no strangers to Americans. From the comedic...hildren,s Disney favorite, "Nemo," fish can talk, ...he silver screen. But can real fish verbally commu...ed in the July 18 issue of the journal Science . ... communications of all vertebrates--in evolutionar...
...HI A new indicator of coral health has been disco...algae called dinoflagellates. The study, released ...s of the National Academy of Sciences, reveals th... more susceptible to disease. , "Corals are fasc...inoflagellates that live inside the coral,s tissue...
... way from the dull hums of the amorous midshipman ...ven to the simplest Celine Dion melody. But the ne...t to mention birdsongs, frog thrums and mating cal...own hundreds of millions of years ago with the hum...e developing brain cells in newly hatched midshipm...
Other Biology News:New indicator uncovered that can predict coral health 2New indicator uncovered that can predict coral health 3From humming fish to Puccini: Vocal communication evolved with ancient species 2
...product has been developed to significantly increa...oteins. Stability is increased at room temperatur.... This product is subjected to 0.2 micron filtrat...lation insures consistently high levels of activit...
Corning brand cover glass squares, 0.16 to 0.19mm thick from Sigma-Aldrich
...uropean Collection of Cell Cultures (ECACC) has be...y, academia and government institutes for over sev...troduce candidates to cell culture and a Level II ... as planning and management of a cell culture labo...
DU 530 Life Science UV/Visible Spectrophotometers from Beckman Coulter
Biology Products: